Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Cardiovascular Diabetology|August 12, 2022
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic controlDamien Denimal, Serge Monier, Isabelle Simoneau, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|April 30, 2011
Efficacy of tube feeding in binge-eating/vomiting patients: a 2-month randomized trial with 1-year follow-upDaniel Jacques Rigaud, Véronique Brayer, Anne Roblot, et al.
Annales D'Endocrinologie|August 22, 2018
Expert opinion on immunotherapy induced diabetesSarra Smati, Perrine Buffier, Benjamin Bouillet, et al.
European Journal of Preventive Cardiology|January 27, 2018
Detection of glucose metabolism disorders in coronary patients enrolled in cardiac rehabilitation: Is glycated haemoglobin useful? Data from the prospective REHABDIAB studySopio Tatulashvili, Bénédicte Patois-Vergès, Amandine Nguyen, et al.
The Journal of Nutrition|August 21, 2009
Liver carbohydrate and lipid metabolism of insulin-deficient mice is altered by trans-10, cis-12 conjugated linoleic acidTony Jourdan, Louiza Djaouti, Laurent Demizieux, et al.
Diabetes|January 30, 2010
CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese miceTony Jourdan, Louiza Djaouti, Laurent Demizieux, et al.
Primary Care Diabetes|January 31, 2024
Tobacco smoking and diabetes. A comparative survey among diabetologists and smoking cessation specialistsIvan Berlin, Vincent Durlach, Daniel Thomas, et al.
Cardiovascular Diabetology|December 5, 2022
Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic reviewAlexia Rouland, David Masson, Laurent Lagrost, et al.
Annales D'Endocrinologie|August 27, 2018
Expert opinion on the metabolic complications of mTOR inhibitorsBenjamin Bouillet, Perrine Buffier, Sarra Smati, et al.
Diabetes|October 5, 2014
Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in miceStephanie Troy-Fioramonti, Laurent Demizieux, Joseph Gresti, et al.
Pageof 16